Buddy Roemer: Me, O...
Health Care: Drugs
Hi-Tech Pharmacal Co. Inc. (HITK: NASDAQ)
$39.98 -0.01 | -0.02%
02/09/12 - 04:00 PM ET
146.30K / 250.40K
Vol / Avg. Vol:40.21 / 39.99
Open / Prev. Close:39.78 - 40.44
Today's Range:18.68 - 44.58
52 Wk Range:2.83%
Performance YTD:TheStreet Rating:
Portfolios with HITK
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- Contributor8 Biotech Stocks to Watch
- ContributorEarnings Short Squeeze Play...
- Contributor10 Small-Cap Value Stocks
- Contributor10 Small-Cap Stocks Trendin...
- UserD and B
- UserxLib Current Longs
- ProBridgeway Ultra-Small Compa...
- ProBridgeway Micro-Cap Limited...
Latest HITK Headlines from TheStreet
- Hi-Tech Pharmacal Stock Hits New 52-Week High (HITK) 11.28.11 | 10:11 am
- 5 Stocks Setting Up to Break Out 11.22.11 | 12:11 pm
- Hi-Tech Pharmacal Reaches New 52-Week High (HITK) 11.15.11 | 04:11 pm
- Hi-Tech Pharmacal Reaches New 52-Week High (HITK) 10.27.11 | 01:10 pm
- Hi-Tech Pharmacal Reaches New 52-Week High (HITK) 09.16.11 | 01:09 pm
- 8 Biotech Stocks to Watch 09.07.11 | 11:09 am
- 5 Heavily Shorted Stocks That Could Pop on Earnings 09.06.11 | 03:09 pm
- Hi-Tech Pharmacal Stock Hits New 52-Week High (HITK) 07.13.11 | 12:07 pm
- Hi-Tech Pharmacal Rises On Unusually High Volume (HITK) 07.07.11 | 02:07 pm
- Hi-Tech Pharmacal Stock Hits New 52-Week High (HITK) 07.05.11 | 10:07 am
Press Releases for HITK
- Hi-Tech Pharmacal Receives Final Approval For Lorazepam Oral Concentrate - Business Wire 01.31.12 | 07:01 am
- Hi-Tech Pharmacal’s ECR Pharmaceuticals Subsidiary Launches Hylase® Wound Gel - Business Wire 01.18.12 | 08:01 am
- Hi-Tech Pharmacal Reports Sales Of $56.9 Million And EPS Of $1.04 For The Second Quarter Ended October 31, 2011 - Business Wire 12.05.11 | 07:12 am
- Hi-Tech Pharmacal To Release Second Quarter Earnings And Hold Conference Call On December 5, 2011 - Business Wire 12.02.11 | 07:12 am
- Hi-Tech Pharmacal To Present At The Rodman & Renshaw Annual Global Investment Conference - Business Wire 09.09.11 | 09:09 am
- Hi-Tech Pharmacal Reports Sales Of $56.2 Million And EPS Of $1.05 For The First Quarter Ended July 31, 2011 - Business Wire 09.07.11 | 08:09 am
- Hi-Tech Pharmacal To Release First Quarter Earnings And Hold Conference Call On September 7, 2011 - Business Wire 09.02.11 | 08:09 am
- Hi-Tech Pharmacal Acquires Rights To TussiCaps® Extended-Release Capsules To Be Promoted By Their ECR Pharmaceuticals Subsidiary - Business Wire 08.25.11 | 08:08 am
- Hi-Tech Licenses Rights To Extended Release Antihistamine/Decongestant For Its ECR Pharmaceuticals Subsidiary - Business Wire 08.25.11 | 07:08 am
- Hi-Tech Pharmacal Reports Record Sales Of $57.2 Million And Diluted EPS Of $1.08 From Continuing Operations For The Fourth Quarter 2011 Ended April 30, 2011 - Business Wire 07.07.11 | 08:07 am
Partner Headlines for HITK
- Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver - Press Releases - Zacks 12.30.11 | 09:12 am
- HiTech Pharmacal Co, Inc. - Momentum - Zacks 12.30.11 | 01:12 am
- Earnings Roundup - Benzinga 12.05.11 | 09:12 am
- These NASDAQ Rockets Should Be In Your Portfolio - Seeking Alpha 10.19.11 | 09:10 am
- Financials Soar, Market Follows - Seeking Alpha 10.13.11 | 07:10 am
- Hi-Tech Pharmacal - Momentum - Zacks 10.03.11 | 01:10 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Earnings Expectations for the Week of July 4 - Benzinga 07.03.11 | 12:07 pm
- Hi-Tech Pharmacal: Bright Future in Generic Drugs - Seeking Alpha 06.28.11 | 09:06 am
- Momentum Ideas: Friday's High Volume Gainers Chased by Big Money Managers - Seeking Alpha 04.17.11 | 07:04 am
